KA
ABBV icon

Kovack Advisors’s AbbVie ABBV Stock Holding History

Kovack Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7
Closed -$3K – 480
2019
Q3 		$3K Sell
7
-4
-36% -$274 ﹤0.01% 491
2019
Q2 		$7K Buy
+11
New +$865 ﹤0.01% 450

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Kovack Advisors's ABBV Position: Q2 2026 in Review

Kovack Advisors reduced its AbbVie (ABBV) stake by 25% in Q2 2026, selling an estimated $1.59M and leaving 22,380 shares worth $5.62M. The position accounts for 0.27% of the portfolio, ranked #72.

Kovack Advisors first reported a position in ABBV in Q3 2015 and has held it in 43 quarters since. The position peaked at $7.06M in Q4 2025. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Kovack Advisors held 22,380 shares of AbbVie worth $5.62M as of Q2 2026.
  • Kovack Advisors sold 7,404 AbbVie shares in Q2 2026, an estimated $1.59M.
  • AbbVie made up 0.27% of Kovack Advisors's portfolio in Q2 2026, its #72 holding.
  • Kovack Advisors first reported a position in AbbVie in Q3 2015 and has held it in 43 quarters since.
  • Kovack Advisors's AbbVie position peaked at $7.06M in Q4 2025.
  • 1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.